S
Shuai Wang
Researcher at Guangdong University of Technology
Publications - 4
Citations - 113
Shuai Wang is an academic researcher from Guangdong University of Technology. The author has contributed to research in topics: Internal medicine & Polyunsaturated fatty acid. The author has an hindex of 1, co-authored 2 publications receiving 45 citations.
Papers
More filters
Journal ArticleDOI
Therapeutic Potential of ω-3 Polyunsaturated Fatty Acids in Human Autoimmune Diseases.
TL;DR: The current understanding of the effects as well as the underlying mechanisms of ω-3 PUFAs on autoimmune diseases is summarized.
Journal ArticleDOI
Adiponectin suppresses tumor growth of nasopharyngeal carcinoma through activating AMPK signaling pathway
Jinlin Du,Hui Shi,Shuai Wang,Yun Jing Yan,Qihua Xu,Sujing Zhou,Zhenggang Zhao,Yun Ping Mu,Chao-Nan Qian,Allan Z. Zhao,Su Mei Cao,Fang-Fang Li +11 more
TL;DR: In this article , the authors investigated the clinical association between circulating adiponectin level and the risk of developing nasopharyngeal carcinoma (NPC) and examined the impact of adipocyte-secreted cytokine on NPC growth both in vitro and in vivo.
Journal ArticleDOI
Adiponectin deficiency promotes endometrial carcinoma pathogenesis and development via activation of mitogen‐activated protein kinase
Yun Jing Yan,Huilian Shi,Zhenggang Zhao,Shuai Wang,Sujing Zhou,Yun Ping Mu,Ning Ding,Yimei Lai,Allan Z. Zhao,Lixian Cheng,Fanghong Li +10 more
TL;DR: Reduction of adiponectin activity promotes EC development, at least in the context of Pten mutation, by activating MAPK.
Journal ArticleDOI
Endogenous production of n-3 polyunsaturated fatty acids protects mice from carbon tetrachloride-induced liver fibrosis by regulating mTOR and Bcl-2/Bax signalling pathways.
Changfeng Shan,Ronghua Wang,Shuai Wang,Zongmeng Zhang,Chaofeng Xing,Wenbin Feng,Zhao Zhenggang,Zhou Sujin,Allan Z. Zhao,Mu Yunping,Li Fanghong +10 more
TL;DR: N−3 PUFA elevation strongly prevented carbon tetrachloride‐induced hepatic damage and inhibited the activation of hepatic stellate cells, suggesting that n−3PUFAs can render strong protective effects against liver fibrosis and point to the potential of mfat‐1 gene therapy as a treatment modality.